Following is a partial transcript of the video (note that errors are possible): ...

RALEIGH, NORTH CAROLINA / ACCESS Newswire / October 8, 2025 / Belhaven Biopharma, a leader in developing innovative intranasal products for emergency use, today announced that the U.S. Food and Drug ...

The lower dose was associated with the need for an additional epinephrine dose, epinephrine infusion, or intubation compared ...

WARREN, N.J., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement ...

For decades, people with severe food allergies had one emergency option: epinephrine injections, which many fear and delay—research shows just 10 to 15% of people administer them promptly during ...

Detailed price information for Aquestive Therapeutics Inc (AQST-Q) from The Globe and Mail including charting and trades.

New patents extend protection for Anaphylm™ into 2037Anaphylm (dibutepinephrine) Sublingual Film, if approved by the FDA, will be the first and ...

Initial $100 million term loan to propel market share growth in the U.S. SAN DIEGO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a commercial-stage biopharmaceutical ...

EpiPens are now regularly carried by the Wisconsin Rapids Police Department after an effort by a family affected by an ...

The first needle-free adrenaline treatment launches in the UK, validating non-invasive delivery with real-world data ...